Abstract
High glycemia variability (GV) has a significant impact on the progression of complications in patients with diabetes mellitus (DM). In the course of research, using the GLINVA program based on the data of continuous glucose monitoring, an in-depth analysis of GV was carried out in 12 patients with type 1 diabetes mellitus who were on the insulin pump therapy and had compensation according to the level of glycated hemoglobin. It was found out that even with good diabetes compensation, the GV remains high enough, which can influence the development of complications. The use of variability indices in assessing the glycemic profile in patients with type 1 diabetes mellitus will help in correcting insulin therapy and timely prevention of complications.
Sign-in/Register to access full text options 
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
